高级检索
当前位置: 首页 > 详情页

MiR-181a regulates the chondrogenic differentiation in pig peripheral blood mesenchymal stem cells

| 认领 | 导出 |

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Kunming Med Univ, Affiliated Hosp 2, Dept Orthoped, Kunming, Yunnan, Peoples R China; [2]Kunming Med Univ, Affiliated Hosp 1, Dept Sports Med, 295 Xichang Rd, Kunming 650032, Yunnan, Peoples R China; [3]People Hosp Dehong State, Dept Orthoped, Kunming, Yunnan, Peoples R China; [4]People Hosp Longchuan Cty, Dept Orthoped, Kunming, Yunnan, Peoples R China
出处:
ISSN:

关键词: Chondrogenesis miR-181a mesenchymal stem cells

摘要:
Articular cartilage injury and therapy are important clinical issues around the world. Mesenchymal stem cells (MSCs) have the ability to differentiate into chondrocytes, which makes MSCs good candidates for use in cartilage repairing. However the regulation and the mechanism of chondrogenesisin MSCs is still unclear. To clarify the factor and mechanism which contribute to the process of chondrogenic differentiation, we focus on miRNAs. Considering the role of miR-181a in chondrogenesis and osteoblast formation, we tested the expression of miR-181a in the induced chondrogenic differential pig PBMSCs by using qRT-PCR. And we identified miR-181a as an up-regulated miRNA in the TGF-ss 3-induced pig PBMSCs chondrogenic differentiation from the early stages and maintained elevated throughout the whole process. After inhibition of the endogenesis miR-181a expression by transfecting the miR-181a inhibitor, the western-blot results and immunofluorescence results indicated that the expression of differentiation-related protein COL2A1, BMP2 were decreased, together with the Alcian blue assay, proving the process of differentiation was inhibited significantly. Taken together, our results demonstrated that miR-181a might be necessary in chondrogenesis of MSCs. Even so, the mechanism of miR-181a on regulating the chondrogenesis still needed to be investigated in future work. And our data would provide an experimental evidence for the research of tissue engineering.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学 4 区 病理学
最新[2023]版:
JCR分区:
出版当年[2018]版:
Q4 PATHOLOGY Q4 ONCOLOGY
最新[2023]版:
Q4 ONCOLOGY Q4 PATHOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Kunming Med Univ, Affiliated Hosp 2, Dept Orthoped, Kunming, Yunnan, Peoples R China;
通讯作者:
通讯机构: [2]Kunming Med Univ, Affiliated Hosp 1, Dept Sports Med, 295 Xichang Rd, Kunming 650032, Yunnan, Peoples R China;
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:53661 今日访问量:0 总访问量:1665 更新日期:2024-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西昌路295号(650032)